1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on India Coronavirus Testing Kits Market
4. Executive Summary
5. Voice of
Customers/Customer Insights
6. India Coronavirus
Testing Kits Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value &
Volume
6.2.
Market Share & Forecast
6.2.1. By Type of Test
(Molecular v/s Serology)
6.2.2. By Use (Disposable
v/s Reusable)
6.2.3. By Full Test Time (5
Minutes, 5- 15 Minutes, 15-60Minutes, 1 Hours- 5 Hours, 5 Hours-12Hours, 12
Hours-24Hours, More Than 1 Days)
6.2.4. By Technology
(RT-PCR, IgG, IgM ELISA Test, Microneutralization Assays)
6.2.5. By Specimen Type
(Nose & Throat Swab, Blood, Sputum, Nasal Aspirate)
6.2.6. By Mobility
(Portable v/s Stationary)
6.2.7. By End Use
(Hospitals, Clinics, Public Health Labs, Private or Commercial Labs, Physician
Labs, Research Institutes, Others)
6.2.8. By Region (North,
East, South, West)
6.2.9. By Company
6.3.
Product Market Map
7. North India Coronavirus
Testing Kits Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value &
Volume
7.2.
Market Share & Forecast
7.2.1. By Type of Test
7.2.2. By Use
7.2.3. By Full Test Time
7.2.4. By Technology
7.2.5. By Specimen Type
7.2.6. By Mobility
7.2.7. By End User
7.2.8. By Top 3 States
8. East India Coronavirus
Testing Kits Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value &
Volume
8.2.
Market Share & Forecast
8.2.1. By Type of Test
8.2.2. By Use
8.2.3. By Full Test Time
8.2.4. By Technology
8.2.5. By Specimen Type
8.2.6. By Mobility
8.2.7. By End User
8.2.8. By Top 3 States
9. South India Coronavirus
Testing Kits Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value &
Volume
9.2.
Market Share & Forecast
9.2.1. By Type of Test
9.2.2. By Use
9.2.3. By Full Test Time
9.2.4. By Technology
9.2.5. By Specimen Type
9.2.6. By Mobility
9.2.7. By End User
9.2.8. By Top 3 States
10. West India Coronavirus
Testing Kits Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value &
Volume
10.2.
Market Share & Forecast
10.2.1. By Type of Test
10.2.2. By Use
10.2.3. By Full Test Time
10.2.4. By Technology
10.2.5. By Specimen Type
10.2.6. By Mobility
10.2.7. By End User
10.2.8. By Top 3 States
11.
Market Dynamics
11.1.
Drivers/Opportunities
11.2.
Challenges/Restraints
12.
Market Trends & Developments
13.
Policy & Regulatory Landscape
14.
Import & Export Analysis
15.
Pricing Analysis
16.
India Economic Profile
17.
Competitive Landscape
17.1.
Company Profiles
17.1.1. Mylab
17.1.2. New Life Company
17.1.3. Cadila Healthcare
17.1.4. Biocon (Syngene)
17.1.5. Eris Lifesciences
17.1.6. Mylan
17.1.7. Gland Pharma
17.1.8. Medsource Ozone
Biomedicals
17.1.9. Helini Biomolecules
17.1.10.
3B BlackBio Biotech
17.1.11.
Alpine Biomedicals
17.1.12.
Immunoscience
17.1.13.
Nulife Care
17.1.14.
Vanguard Diagnostics
17.1.15.
Voxtur Bio
17.1.16.
CPC Diagnostics
17.1.17.
HLL Lifecare
18.
Strategic Recommendations
19.
About Us & Disclaimer